Last reviewed · How we verify

NCT04972695

Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images

Completed Last updated 28 February 2022
What this trial tests

trial testing Fundus Photographs (retinographies) in Glaucoma, Suspect in 615 participants. Completed in 23 February 2022.

Timeline
7 May 2021
Primary endpoint
23 February 2022
23 February 2022

Quick facts

Lead sponsorInstituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
StatusCompleted
Study typeOBSERVATIONAL
Enrollment615
Start date7 May 2021
Primary completion23 February 2022
Estimated completion23 February 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

Who can join

40 and older, any sex, with Glaucoma, Suspect or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical, cross-sectional and prospective study to assess the images of the posterior pole of the retina of patients from the Glaucoma Unit of the IOBA and the Hospital Clínico Universitario de Valladolid during the period between May and December 2021. The aim of the project is to provide a sufficient number of images from posterior pole retinographies in patients with suspected glaucoma or with diagnosis of glaucoma in order to determine the sensitivity and specificity of an automatic glaucoma screening algorithm developed by the company Transmural Biotech S.L.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Glaucoma, Suspect

Currently open trials in the same condition.

Other Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04972695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing